Neuroendocrine, Autonomic, and Metabolic Responses to an Orexin Antagonist, Suvorexant, in Psychiatric Patients with Insomnia

| April 1, 2017 | 0 Comments

by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD
Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital, in Hiroshima, Japan, and Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, in Yamaguchi, Japan.

Innov Clin Neurosci. 2017;14(3–4):30–37

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , ,

Category: Anxiety Disorders, Depression, Original Research, Past Articles, Psychiatry, Psychopharmacology, Sleep Disorders

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.